Cargando…

Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM) is a neuroinflammatory disease, causing various neurological symptoms, including motor, sensory, and bladder and bowel dysfunctions. This study was designed to reveal the impact of HAM and related symptoms on health-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Miyuna, Yamauchi, Junji, Sato, Tomoo, Yagishita, Naoko, Araya, Natsumi, Aratani, Satoko, Tanabe, Kenichiro, Horibe, Erika, Watanabe, Toshiki, Coler-Reilly, Ariella, Nagasaka, Misako, Akasu, Yukari, Kaburagi, Kei, Kikuchi, Takayuki, Shibata, Soichiro, Matsumoto, Hirofumi, Koseki, Akihito, Inoue, Soichiro, Takata, Ayako, Yamano, Yoshihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036434/ https://www.ncbi.nlm.nih.gov/pubmed/35479934 http://dx.doi.org/10.3389/fmed.2022.879379

Ejemplares similares

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan
por: Iijima, Naoki, et al.
Publicado: (2021)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net)
por: Coler-Reilly, Ariella L. G., et al.
Publicado: (2016)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Tamaki, Keiko, et al.
Publicado: (2019)

Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1
por: Tanaka, Yukie, et al.
Publicado: (2022)

HAM-net national patient registration system reveals details of how Japanese patients with HTLV-1-associated myelopathy/tropical spastic paraparesis progress over time
por: Coler-Reilly, Ariella, et al.
Publicado: (2015)

Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system
por: Coler-Reilly, Ariella LG, et al.
Publicado: (2014)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Clinical Pathophysiology of Human T-Lymphotropic Virus-Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2012)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamakawa, Natsuko, et al.
Publicado: (2020)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
por: Araya, Natsumi, et al.
Publicado: (2011)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)
por: Yamauchi, Junji, et al.
Publicado: (2022)

Patient satisfaction survey for HAM-net registrants
por: Sato, Kentaro, et al.
Publicado: (2015)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Sato, Tomoo, et al.
Publicado: (2013)

HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients
por: Araya, Natsumi, et al.
Publicado: (2015)

Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP
por: Sato, Tomoo, et al.
Publicado: (2014)

Importance of E3 ubiquitin ligase Synoviolin in fibrogenesis
por: Yagishita, Naoko, et al.
Publicado: (2012)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

Evaluation of clinical outcome measures for HAM/TSP
por: Kikuchi, Takayuki, et al.
Publicado: (2015)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

SPACIA1/SAAL1: a newly identified gene associated with aberrant proliferation of synovial fibroblasts
por: Sato, Tomoo, et al.
Publicado: (2012)

Parkinsonism in a Patient with Human T-lymphotropic Virus 1 Myelopathy
por: Afzal, Hasnain, et al.
Publicado: (2018)

Synoviolin meets metabolic disorders
por: Yagishita, Naoko, et al.
Publicado: (2012)

A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy
por: Ishihara, Makoto, et al.
Publicado: (2015)

Abnormally High Levels of Virus-Infected IFN-γ(+)CCR4(+)CD4(+)CD25(+) T Cells in a Retrovirus-Associated Neuroinflammatory Disorder
por: Yamano, Yoshihisa, et al.
Publicado: (2009)

A three-factor plasma diagnostic model of human T -cell leukemia virus-1 associated myelopathy
por: Ishihara, Makoto, et al.
Publicado: (2015)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis
por: YAGISHITA, NAOKO, et al.
Publicado: (2012)

Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives
por: Sá, Katia N, et al.
Publicado: (2015)

Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2019)

Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy
por: Matsuo, Tomohiro, et al.
Publicado: (2018)

Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings
por: Petscavage, Jonelle M., et al.
Publicado: (2015)

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
por: Taylor, Graham P, et al.
Publicado: (2006)

Vulnerability to traumatic stress in fibromyalgia patients: 19 month follow-up after the great East Japan disaster
por: Usui, Chie, et al.
Publicado: (2013)

A Caucasian Australian presenting with human T-lymphotropic virus type I associated myelopathy: a case report
por: Faull, Matthew, et al.
Publicado: (2014)

Signs, meanings and practices of people living with human t-cell lymphotropic virus type 1 or tropical spastic myelopathy
por: Santana, Genildes Oliveira, et al.
Publicado: (2020)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4dia7e0ht5q0stbi2qjnmlpk5j